|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5695 USD | -0.26% |
|
-3.47% | -3.06% |
| Apr. 16 | VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
VBI Vaccines Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 8.68 million compared to USD 1.08 million a year ago. Net loss was USD 92.84 million compared to USD 113.3 million a year ago.
Basic loss per share from continuing operations was USD 6.03 compared to USD 13.16 a year ago. Diluted loss per share from continuing operations was USD 6.03 compared to USD 13.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.06% | 16.23M | |
| +0.67% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +6.55% | 24.63B | |
| -21.66% | 18.2B | |
| +29.96% | 12.01B | |
| -1.57% | 11.76B | |
| +16.03% | 10.4B | |
| -4.80% | 9.94B |
VBI VACCINES INC. 
